Blog

  • Human stem cell-derived RPE shows safety, improved vision in GA
    DENVER — In a phase 1b trial, subretinal delivery of a human stem cell-derived retinal pigment epithelium yielded visual improvements in patients with advanced geographic atrophy, according to a speaker.“This study looked at subretinal stem cell implants through a pars plana vitrectomy surgery, where we created a bleb directly over the site of geographic atrophy,” […]
  • Sutureless posterior chamber IOL has good long-term outcomes
    Patients who underwent sutureless scleral fixation of a one-piece IOL had good outcomes at 5 years, according to a study published in Journal of Refractive Surgery.Agostino S. Vaiano, MD, PhD, of Santa Croce e Carle Hospital, Cuneo, Italy, and colleagues wrote that while previous studies have explored both sutured and sutureless posterior chamber IOLs, data […]
  • FDA clears Be Free Day toric contact lenses
    Editor’s note: This is a developing news story. Please check back soon for updates.The FDA cleared Be Free Day toric contact lenses for the correction of myopia and other refractive errors, according to a press release from Euclid Vision.Be Free Day (toufilcon B) silicone hydrogel toric lenses are set to launch this fall with the […]
  • Embrace next-generation IOL optics to expand patient vision
    The historical paradigm of cataract surgery forced an absolute compromise: pristine distance vision with absolute spectacle dependence or an expanded range of vision at the cost of contrast sensitivity and night dysphotopsia.Today, next-generation nondiffractive designs are shifting those boundaries, reshaping how we counsel patients and tailor premium visual outcomes.For decades, premium cataract surgery was defined […]
  • Is MAHA ready for the health challenges of rural America?
    This month’s Healio Exclusive focuses on one of the most complex — and frankly saddest — realities in American health care: the profound unmet needs of rural populations, particularly with respect to access to care.We also explore whether HHS Secretary Robert F. Kennedy Jr.’s “Make America Healthy Again” (MAHA) initiative is prepared to meaningfully address […]
  • Prescribing Qlosi ‘did not cannibalize optical sales’
    PHOENIX — Prescribing Qlosi eye drops for presbyopia was not associated with a reduction in optical purchases or other practice performance metrics, according to a study presented here.“The questions that kept coming up among our physicians were straightforward: Is this going to hurt us? Are patients going to stop buying glasses? Are we going to […]
  • ‘Typically benign’ retinal venous malformations need neuroimaging
    PHOENIX — Patients diagnosed with retinal venous malformations should always undergo additional imaging to rule out microvascular or cerebral changes, according to a poster here.“Retinal venous malformations are an abnormal vessel, typically a vein, which crosses the horizontal raphe and passes through the macula,” Brittney Brady, OD, FAAO, associate professor at Illinois College of Optometry, […]
  • Saptalis launches cyclosporine ophthalmic emulsion 0.05%
    Saptalis Pharmaceuticals launched generic cyclosporine ophthalmic emulsion 0.05% for the treatment of dry eye disease, according to press release.According to the release, the eye drop, a generic of Restasis (cyclosporine ophthalmic emulsion 0.05%, AbbVie), will be available in 30- and 60-count single-use vials. It is indicated for increasing tear production, providing “a convenient option for […]
  • Interventional approach needed in pseudophakic glaucoma patients
    MIAMI — Combining minimally invasive glaucoma surgery with pharmaceutical drug delivery is an option to lower IOP in patients who are pseudophakic, according to a speaker.At Sunshine Eye & Retina, Zarmeena Vendal, MD, urged ophthalmologists to avoid eye drops and incisional surgery when possible in patients who previously underwent cataract surgery. Instead, they should prioritize […]
  • New e-book is ‘chairside reference’ for nutrition in eye care
    Nutrition can be a significant factor in the management of ocular diseases, but are doctors incorporating that into their care?A recently published e-book aims to be a guide to ocular nutrition that optometrists can refer to in daily practice.“Ocular Nutrition Handbook for the Practicing Optometrist” offers nutritional advice for more than 30 conditions, from age-related […]
  • FDA approves updated Spectralis retinal imaging software
    The FDA approved updated software for the Spectralis retinal imaging platform, according to a press release from Heidelberg Engineering.The update enables a 250 kHz scan speed for OCT angiography (OCTA), “complementing the existing 85 kHz and 125 kHz scan speeds.”The faster scan speed “can be meaningful for practices where efficiency and patient experience are essential […]
  • Transient IOP increase observed after corneal cross-linking
    Patients who underwent corneal cross-linking for keratoconus had a temporary but statistically significant increase in IOP in the months after the procedure, according to a study published in Journal of Glaucoma.“The relationship between post-CXL biomechanical changes and tonometry in human eyes is not well understood, with studies reporting variable results in postoperative IOP measurements,” Wufan […]
  • Protecting access to cataract surgery through unified action
    For more than 30 years, I have had the privilege of helping patients regain visual clarity, independence and confidence through cataract surgery.It is one of the safest and most transformative procedures in all of medicine. And yet, every year, the environment surrounding Medicare reimbursement grows more complicated and more concerning. This past year offered a […]
  • Lacripep for neurotrophic keratitis gets FDA designations
    The FDA granted orphan drug designation and fast track designation to Lacripep, according to a press release from TearSolutions. If approved, Lacripep would be the second treatment indicated for neurotrophic keratitis.In addition, the first patients have been dosed in a phase 2 multicenter, randomized clinical trial of Lacripep, the company said.The topical therapy is a […]
  • Perform cataract surgery midway between anti-VEGF injections
    KIAWAH ISLAND, S.C. — Cataract surgery should be performed midway between any anti-VEGF injections a patient may be receiving, Steve Charles, MD, said at Kiawah Eye and Retina.“I’ve heard people say … ‘Just for your convenience, we’ll do the injection while you’re in the OR, having cataract surgery,’” Charles said during his presentation.{{VIDEO}}“It is absolutely […]